Skip to content

Sensors for HEalth Recording and Physical Activity Monitoring

Sensors for HEalth Recording and Physical Activity Monitoring

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03673189
Acronym
SHERPAM
Enrollment
30
Registered
2018-09-17
Start date
2018-06-28
Completion date
2019-09-12
Last updated
2023-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical Activity

Keywords

Sensors, Health Recording

Brief summary

The SHERPAM project is part of a scientific and technological context which aim is to record, transmit, analyse the physiological parameters of a patient, as well as to record the feedback to the patient and health professional to suggest the best individualised attitude. The questions of SHERPAM are generic. However, two specific applications will be addressed, in which the partners have already acquired some expertise: the recognition and quantification of physical activity with energy expenditure estimation, and the assessment of walking ability in patients with obliterative vascular disease in the lower limbs. Another application concerns the monitoring of the practice of physical activity and some biological signs in subjects with cardiovascular risk and in cardiac patients (arrhythmogenic diseases). Despite various clinical contexts and health goals, a common approach will be developed.

Detailed description

To assess the SHERPAM Device (DS) by the continuous acquisition and transmission of data (accelerations, rotations, alterations in thoracic volume, heart rate, electrocardiogram) in a real life physical activity practice (subjects in their living environment and during their usual physical practices) using the DS's real-time communication tools, automatic data processing, and the DS's ability to produce information.

Interventions

DEVICEsensors

Acquisition and transmission of exploitable recordings in the public targeted by the DS, that is to say which allow to draw clinical information in relation to the objectives of the DS (detection of the cardiac rhythm): data without artefact (saturation), in a good signal to noise ratio.

Sponsors

LTSI-INSERM U1099
CollaboratorUNKNOWN
CIC-IT 14-14
CollaboratorUNKNOWN
Rennes University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Intervention model description

Prospective, monocentric, with healthy volunteers and patients

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers Healthy active subjects aged 50 or over (ie without diagnosed disease, without chronic treatment) and recruited in the sports associations of Ille et Vilaine (cycle tourism clubs). * having benefited from an oral or written prescription of physical activity carried out by a health professional and applying this prescription daily in autonomy or in a sports club. Common to all subjects * physically active (adherent to a club or sports association or practicing independently according to the recommendations of their physician); * practicing at least once a week; * residence located less than 100 km return from Rennes University Hospital * affiliate or beneficiary of a social protection scheme; * having given his written consent

Exclusion criteria

Common to all subjects * wearing a pacemaker or implanted cardiac defibrillator (precaution because using telemetry); * participation in another research protocol; * persons aver 18 yrs-old subject to legal protection (legal safeguards, guardianship, tutorship), persons deprived of their liberty; * pregnant or nursing woman.

Design outcomes

Primary

MeasureTime frameDescription
asses the continuous acquisition of data by sensorsevery day (during 3 weeks)transmission and reception of physiological parameters of a patient

Secondary

MeasureTime frameDescription
Test acceptability of SHERPAM Deviceafter 7 days of usequestionnary
Test acceptability of Sherpam Deviceafter 21 days of usequestionnary
Test usability of Sherpam Deviceafter 7 days of usequestionnary

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026